Avience Biomedicals (NSE:AVIENCE) Retained Earnings: ₹101.6 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AVIENCE Avience Biomedicals Ltd NSE:AVIENCE
18 GF Score
Price ₹250.90
! 3 Warning Signs
View Full Analysis

What is Avience Biomedicals Retained Earnings?

Avience Biomedicals NSE:AVIENCE +1.17% 18 Retained Earnings is ₹101.6 Mil as of Mar. 2025. GuruFocus rates NSE:AVIENCE with a GF Score™ of 18/100. The stock has 3 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Avience Biomedicals's retained earnings for the quarter that ended in Mar. 2025 was ₹101.6 Mil.

Avience Biomedicals's quarterly retained earnings increased from Mar. 2023 (₹7.9 Mil) to Mar. 2024 (₹29.3 Mil) and increased from Mar. 2024 (₹29.3 Mil) to Mar. 2025 (₹101.6 Mil).

Avience Biomedicals's annual retained earnings increased from Mar. 2023 (₹7.9 Mil) to Mar. 2024 (₹29.3 Mil) and increased from Mar. 2024 (₹29.3 Mil) to Mar. 2025 (₹101.6 Mil).


Avience Biomedicals  (NSE:AVIENCE) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Avience Biomedicals Retained Earnings Historical Data

* Premium members only.

The historical data trend for Avience Biomedicals's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avience Biomedicals Retained Earnings Chart

Avience Biomedicals Annual Data
Trend Mar23 Mar24 Mar25
Retained Earnings
7.85 29.26 101.58

Avience Biomedicals Semi-Annual Data
Mar23 Mar24 Mar25
Retained Earnings 7.85 29.26 101.58
NSE:AVIENCE
18GF Score
Avience Biomedicals Ltd NSE:AVIENCE
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avience Biomedicals Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of ₹101.6 Mil mean?
Avience Biomedicals (NSE:AVIENCE) has a Retained Earnings of ₹101.6 Mil as of Mar. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on Avience Biomedicals and its competitors.
Is Avience Biomedicals' Retained Earnings too high?
Avience Biomedicals' current Retained Earnings is ₹101.6 Mil. Overall, Avience Biomedicals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Retained Earnings compare to ABT and SYK?
Avience Biomedicals' Retained Earnings of ₹101.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Avience Biomedicals and its competitors. Avience Biomedicals's current Retained Earnings is ₹101.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Retained Earnings of ₹101.6 Mil. The current Retained Earnings is ₹101.6 Mil. Avience Biomedicals' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Retained Earnings is ₹101.6 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avience Biomedicals Business Description

Address C-11, Block-C, Community Centre, Unit No-2, 1st Floor, Janakpuri A-3, New Delhi, IND, 110058
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
18GF Score

Get the complete analysis for NSE:AVIENCE

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹250.90
Price